| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/10/2004 | US20040110736 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/10/2004 | US20040110735 Methods of activating receptor using amphiphilic drug-oligomer conjugates |
| 06/10/2004 | US20040110734 Combinations for the treatment of inflammatory disorders |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110725 Pyridazines as interleukin-1beta converting enzyme inhibitors |
| 06/10/2004 | US20040110718 Anti-HCV nucleoside derivatives |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110282 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 06/10/2004 | US20040110270 Bacterial composition and its use |
| 06/10/2004 | US20040109865 Antibody composition-containing medicament |
| 06/10/2004 | US20040109857 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | US20040109843 Pharmaceutical composition containing decoy and use of the same |
| 06/10/2004 | CA2506948A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 06/10/2004 | CA2506895A1 Cannabinoid receptor ligands |
| 06/10/2004 | CA2506607A1 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | EP1426374A1 Naphthyridine derivative |
| 06/09/2004 | EP1426360A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 06/09/2004 | EP1426055A1 Targeted protein degradation vehicles (tpdvs), nucleic acid constructs encoding them and their use |
| 06/09/2004 | EP1426050A1 Jnk inhibitors |
| 06/09/2004 | EP1425587A2 Method for identifying anti-inflammatory drugs |
| 06/09/2004 | EP1425580A2 Lymphatic endothelial cells materials and methods |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425381A2 Emu-based formulations for wound treatment related application information |
| 06/09/2004 | EP1425308A2 Polysaccharidic esters of retinoic acid |
| 06/09/2004 | EP1425306A2 Nanoparticles comprising biologically active tnf which is immobilised on the same |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425281A1 Chemical compounds |
| 06/09/2004 | EP1425280A2 Hetero-bicyclic crf antagonists |
| 06/09/2004 | EP1425277A2 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1425042A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425014A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 06/09/2004 | EP1425010A1 Substituted indoles and their use as integrin antagonists |
| 06/09/2004 | EP1425005A1 Pharmaceutical compostion comprising lumiracoxib |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424971A1 Eustachian tube stent |
| 06/09/2004 | EP1424957A2 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/09/2004 | EP1424894A2 Inhibition of pathological angiogenesis in vivo |
| 06/09/2004 | EP1276742B1 Process for the preparation of pyrazolopyridine derivatives |
| 06/09/2004 | EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 06/09/2004 | EP1212323B1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/09/2004 | EP1171441B1 Morphinoid compounds |
| 06/09/2004 | EP1148875B1 Methods and compositions to enhance white blood cell count |
| 06/09/2004 | EP1043978B1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 06/09/2004 | EP0956294B1 Thrombin inhibitors |
| 06/09/2004 | DE10320633A1 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus |
| 06/09/2004 | DE10320603A1 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1503673A antiinflammation agents |
| 06/09/2004 | CN1503672A 6-substituted pyrido-pyrimidines |
| 06/09/2004 | CN1503671A Agent for topical ophthalmic treatment of ocular inflammatory diseases |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502632A Novel TNFR-FC fusion protein |
| 06/09/2004 | CN1502629A Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/09/2004 | CN1502616A Method for the preparation of citalopram |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502608A Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity |
| 06/09/2004 | CN1502364A Medicine for treating rheumatism and rheumatoid disease, and productive technology thereof |
| 06/09/2004 | CN1502360A Medicated liquor for dispelling wind, removing alampness and relieving pain, and preparation process thereof |
| 06/09/2004 | CN1502353A Compound chuanxiong and angelica total extract and preparation, use thereof |
| 06/09/2004 | CN1502350A Traditional Chinese medicine composition (Fujangtieda liquor) for curing traumatic injury |
| 06/09/2004 | CN1502349A Traditional Chinese medicine composition (Bushenzhuangyao Decoction) for reinforcing kidney and strengtening lumbar |
| 06/09/2004 | CN1502328A Lamiophlomis rotate dispersion table preparation process |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152873C Novel diphenyl-piperidine derivate |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152864C Phenylphenanthridines with PDE-IV inhibiting activity |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152696C Repercusion analgesia ointment and production method htereof |
| 06/09/2004 | CN1152694C Traditional Chinese medicine mixture for treating chronic bronchitis |
| 06/09/2004 | CN1152691C Use of chemically-stabilized chloride solution for inhibiting antigen-specific immune response |
| 06/09/2004 | CN1152690C Composite Triamcinolone Acetonide medicine for treating germ-free inflammation |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747132 Methods for the synthesis of a modified hemoglobin solution |
| 06/08/2004 | US6747061 N-substituted dithiocarbamates for the treatment of biological disorders |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747043 Alkoxy aryl β2 adrenergic receptor agonists |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/08/2004 | US6747016 Substituted purine derivatives as inhibitors of cell adhesion |
| 06/08/2004 | US6747013 Such as rheumatoid arthritis; gene therapy, such as to replace a defective apoptotic gene, to cells in the affected area |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | US6746673 For prophylaxis and/or treatment of an autoimmune disease or rheumatoid arthritis |
| 06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |